Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 17, 2013
Evaluating negative-symptom-like behavioural changes in developmental models of schizophreniaPaul MoserHandbook of Experimental Pharmacology|October 10, 2019
Out of Control? Managing Baseline Variability in Experimental Studies with Control GroupsPaul MoserEuropean Journal of Pharmacology|June 25, 2009
Use of latency to immobility improves detection of antidepressant-like activity in the behavioral despair test in the mouseVincent Castagné, Roger D Porsolt, Paul MoserJournal of Pharmacological and Toxicological Methods|September 28, 2010
Current approaches and issues in non-clinical evaluation of abuse and dependencePaul Moser, Toni Wolinsky, Vincent Castagné, et al.The Journal of Pharmacology and Experimental Therapeutics|November 25, 2010
How good are current approaches to nonclinical evaluation of abuse and dependence?Paul Moser, Toni Wolinsky, Mark Duxon, et al.Current Protocols in Neuroscience|April 5, 2011
Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and miceVincent Castagné, Paul Moser, Sylvain Roux, et al.Current Protocols in Pharmacology|February 2, 2012
Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and miceVincent Castagné, Paul Moser, Sylvain Roux, et al.European Journal of Pharmacology|February 29, 2008
Continuous stimulation of dopaminergic receptors by rotigotine does not interfere with the sleep-wake cycle in the ratDieter Scheller, Nick Dürmüller, Paul Moser, et al.Journal of Pharmacological and Toxicological Methods|January 25, 2020
Regulatory safety pharmacology evaluation of BIA 10-2474A Wallace Hayes, Peter Pressman, Paul Moser, et al.Critical Reviews in Toxicology|February 2, 2021
Non-clinical toxicology evaluation of BIA 10-2474A Wallace Hayes, Klaus Weber, Paul Moser, et al.Pageof 2